Page 218 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 218

208        ELECTROLYTE DISORDERS



             48. Dougherty SA, Center SA, Dzanis DA. Salmon calcitonin  69. Gunther R, Felice LJ, Nelson RK. Toxicity of a vitamin
                 as adjunct treatment for vitamin D toxicosis in a dog. J Am  D 3 rodenticide to dogs. J Am Vet Med Assoc
                 Vet Med Assoc 1990;196:1269–72.                     1988;193:211–4.
             49. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of  70. Hansen B, DiBartola SP, Chew DJ, et al. Clinical and
                 cats with naturally-occurring chronic renal failure: effect  metabolic findings in dogs with spontaneous chronic renal
                 of  dietary  management.  J  Small  Anim  Pract     failure fed two different diets. Am J Vet Res
                 2000;41:235–42.                                     1992;53:326–34.
             50. Emmett M. A comparison of clinically useful phosphorus  71. Hare R, Dobbs C, Sayman K, et al. Calcipotriene poison-
                 binders for patients with chronic renal failure. Kidney Int  ing in dogs. Vet Med 2000;95:770–8.
                 2004;66:S25–S32.                                 72. Harkin KR, Braselton WE, Tvedten H. Pseudohypophos-
             51. Fan TM, Simpson KW, Trasti S, et al. Calcipotriol toxicity  phatemia in two dogs with immune-mediated hemolytic
                 in a dog. J Small Anim Pract 1998;39:581–6.         anemia. J Vet Intern Med 1998;12:178–81.
             52. Feldman EC, Nelson RW. Disorders of growth hormone.  73. Harper EJ, Hackett RM, Wilkinson J, et al. Age-related
                 In: Canine and feline endocrinology and reproduction.  variations in hematologic and plasma biochemical test
                 2nd ed. Philadelphia: WB Saunders; 1996. p. 60.     results in beagles and Labrador retrievers. J Am Vet
             53. Finco DR. The role of phosphorus restriction in the  Med Assoc 2003;223:1436–42.
                 management of chronic renal failure in the dog and cat.  74. Henik RA, Forrest LJ, Friedman AL. Rickets caused by
                 In: Proc 7th Kal Kan Symposium. 1983. p. 131–4.     excessive renal phosphate loss and apparent abnormal vita-
             54. Finco DR, Cornelius LM. Characterization and treatment  min D metabolism in a cat. J Am Vet Med Assoc
                 of water, electrolyte, and acid-base imbalances of induced  1999;215:1644–9.
                 urethral obstruction in the cat. Am J Vet Res    75. Hercz G, Coburn JW. Prevention of phosphate retention
                 1977;38:823–30.                                     and hyperphosphatemia in uremia. Kidney Int 1987;32:
             55. Finco DR, Duncan JR, Schall WD, et al. Chronic enteric  S215–S220.
                 disease and hypoproteinemia in 9 dogs. J Am Vet Med  76. Ibels LS, Alfrey AC, Haut L, et al. Preservation of function
                 Assoc 1973;163:262–71.                              in experimental renal disease by dietary restriction of
             56. Finco DR, Barsanti JA, Brown SA. Influence of dietary  phosphate. N Engl J Med 1978;298:122.
                 source of phosphorus on fecal and urinary excretion of  77. Ikeuchi J, Yoshizaki T, Hirata M. Plasma biochemistry
                 phosphorus and other minerals by male cats. Am J Vet  values  of  young  beagle  dogs.  J  Toxicol  Sci
                 Res 1989;50:263–6.                                  1991;16:49–59.
             57. Finco DR, Brown SA, Crowell WA, et al. Effects of dietary  78. Jorgensen LS, Center SA, Randolph JF, et al. Electrolyte
                 phosphorus and protein in dogs with chronic renal failure.  abnormalities induced by hypertonic phosphate enemas in
                 Am J Vet Res 1992;53:2264–71.                       two cats. J Am Vet Med Assoc 1985;187:1367–8.
             58. Fischer D, Cline K, Plone M, et al. Results of a randomized  79. Juan D, Elrazak MA. Hypophosphatemia in hospitalized
                crossover study comparing once-daily and thrice-daily  patients. JAMA 1979;242:163–4.
                sevelamer dosing. Am J Kid Dis 2006;48:437–44.    80. Justin RB, Hohenhaus AE. Hypophosphatemia associated
             59. Fitzgerald F. Clinical hypophosphatemia. Annu Rev Med  with enteral alimentation in cats. J Vet Intern Med
                 1978;29:177–89.                                     1995;9:228–33.
             60. Fooshee SK, Forrester SD. Hypercalcemia secondary to  81. Kaehny WD, Hegg AP, Alfrey AC. Gastrointestinal
                 cholecalciferol rodenticide toxicosis in two dogs. J Am  absorption of aluminum from aluminum-containing
                 Vet Med Assoc 1990;196:1265–8.                      antacids. N Engl J Med 1977;296:1389–90.
             61. FournierA,MoriniereP,SebertJL,etal.Calciumcarbonate,  82. Kallet AJ, Richter KP, Feldman EC, et al. Primary hyper-
                 an aluminum-free agent for control of hyperphosphatemia,  parathyroidism in cats: seven cases (1984–1989). J Am Vet
                 hypocalcemia, and hyperparathyroidism in uremia. Kidney  Med Assoc 1991;199:1767–71.
                 Int 1986;29:S114–S119.                           83. Kaplan MA, Canterbury JM, Bourgoignie JJ, et al. Rever-
             62. Fraser D, Hones G, Kooh SW, et al. Calcium and phos-  sal of hyperparathyroidism in response to dietary phos-
                 phate metabolism. In: Tietz NW, editor. Fundamentals  phorus restriction in the uremic dog. Kidney Int
                 of clinical chemistry. Philadelphia: WB Saunders; 1987.  1979;15:43.
                 p. 705–728.                                      84. Karlinsky ML, Haut L, Buddington B, et al. Preservation
             63. Fricker S. The therapeutic application of lanthanides.  of renal function in experimental glomerulonephritis.
                 Chem Soc Rev 2006;35:524–33.                        Kidney Int 1980;17:293.
             64. Froment DH, Molitoris BA, Buddington B, et al. Site and  85. Kassirer  JP,  Hricik  DE,  Cohen  JJ.  Phosphate.
                 mechanism of enhanced gastrointestinal absorption of  In: Repairing body fluids: principles and practice.
                 aluminum by citrate. Kidney Int 1989;36:978–84.     Philadelphia: WB Saunders; 1989. p. 110–117.
             65. Fuller TJ, Carter NW, Barcenas C, et al. Reversible  86. Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic
                 changes of the muscle cell in experimental phosphorus  changes  in  serum  phosphorus  level  in  diabetic
                 deficiency. J Clin Invest 1976;57:1019–24.          ketoacidosis. Am J Med 1985;79:571–6.
             66. Fuller TJ, Nichols WW, Brenner BJ, et al. Reversible  87. Klausner JS, O’Leary TP, Osborne CA. Calcium urolith-
                 depression in myocardial performance in dogs with   iasis in two dogs with parathyroid adenomas. J Am Vet
                 experimental phosphorus deficiency. J Clin Invest   Med Assoc 1987;191:1423–6.
                 1978;62:1194–200.                                88. Knochel  JP.  The  pathophysiology  and  clinical
             67. Fulton RB, Fruechte LK. Poisoning induced by adminis-  characteristics of severe hypophosphatemia. Arch Intern
                 tration of a phosphate-containing urinary acidifier in a cat.  Med 1977;137:203–20.
                 J Am Vet Med Assoc 1991;198:883–5.               89. Knochel JP. Skeletal muscle in hypophosphatemia and
             68. Glick MR, Ryder KW, Glick SJ. Interferographs.      phosphorus  deficiency.  Adv  Exp  Med   Biol
                 Indianapolis: Science Enterprises Inc; 1991.        1978;103:357–66.
   213   214   215   216   217   218   219   220   221   222   223